Drug recall D-0649-2016
Product
Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68
Reason for recall
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Lots and codes
Lot #: M07862, Exp 05/2018; M07865, Exp 06/2018
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 116,400 bottles
- Distribution
- Nationwide and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 11, 2016
- Terminated
- April 24, 2017
Related products
- Lyrica – drug information
- NDC 0071-1018 Lyrica · Pregabalin 300 mg/1 · Parke-Davis Div of Pfizer Inc